1. Zhang, Rongju, Zhang, Shaohui, Xing, Rongge, Zhang, Qin. 2019. High expression of EZR (ezrin) gene is correlated with the poor overall survival of breast cancer patients. In Thoracic cancer, 10, 1953-1961. doi:10.1111/1759-7714.13174. https://pubmed.ncbi.nlm.nih.gov/31452341/
2. Xiao, Guodong, Cheng, Feng, Yuan, Jing, Wang, Peili, Fan, Huijie. 2022. Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer. In Oncology research, 30, 35-51. doi:10.32604/or.2022.026616. https://pubmed.ncbi.nlm.nih.gov/37304008/
3. Xu, Jian, Zhang, Wei. 2021. EZR promotes pancreatic cancer proliferation and metastasis by activating FAK/AKT signaling pathway. In Cancer cell international, 21, 521. doi:10.1186/s12935-021-02222-1. https://pubmed.ncbi.nlm.nih.gov/34627255/
4. García-Solís, Blanca, Van Den Rym, Ana, Martinez-Martínez, Laura, de la Calle-Martín, Oscar, Pérez de Diego, Rebeca. 2023. Inherited human ezrin deficiency impairs adaptive immunity. In The Journal of allergy and clinical immunology, 152, 997-1009.e11. doi:10.1016/j.jaci.2023.05.022. https://pubmed.ncbi.nlm.nih.gov/37301410/
5. Zhang, Xiao-Dan, Huang, Guo-Wei, Xie, Ying-Hua, Li, En-Min, Xu, Li-Yan. . The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells. In Nucleic acids research, 46, 1793-1809. doi:10.1093/nar/gkx1259. https://pubmed.ncbi.nlm.nih.gov/29253179/
6. Tabur, Suzan, Oztuzcu, Serdar, Oguz, Elif, Ozkaya, Mesut, Demiryürek, Abdullah T. 2016. Evidence for elevated (LIMK2 and CFL1) and suppressed (ICAM1, EZR, MAP2K2, and NOS3) gene expressions in metabolic syndrome. In Endocrine, 53, 465-70. doi:10.1007/s12020-016-0910-0. https://pubmed.ncbi.nlm.nih.gov/26956845/